AVALO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Item 1.01. Entry into a Material Definitive Agreement. On May 31, 2023, Avalo Therapeutics, Inc. entered into an exchange agreement with entities affiliated with Venrock Healthcare Capital... | June 2, 2023
Source: marketscreener.com